We are live on ! Find out more
TMCI icon

Treace Medical Concepts

119 hedge funds and large institutions have $260M invested in Treace Medical Concepts in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more call options, than puts

Call options by funds: $27K | Put options by funds: $3K

23% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 35

15% more capital invested

Capital invested by funds: $226M → $260M (+$34.2M)

0.34% more ownership

Funds ownership: 61.11%61.46% (+0.34%)

5% less funds holding

Funds holding: 125119 (-6)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

Holders
119
Holders Change
-6
Holders Change %
-4.8%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
15
Increased
43
Reduced
35
Closed
21
Calls
$27K
Puts
$3K
Net Calls
+$24K
Net Calls Change
+$11K
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
51
Jane Street
New York
$306K +$46.6K +7,141 +19%
Russell Investments Group
52
Russell Investments Group
United Kingdom
$263K -$13.6K -2,085 -5%
GPGA
53
Grandeur Peak Global Advisors
Utah
$251K
Franklin Resources
54
Franklin Resources
California
$242K +$8.72K +1,335 +4%
Raymond James Financial
55
Raymond James Financial
Florida
$234K -$90.5K -13,859 -28%
BIG
56
Brooklyn Investment Group
New York
$224K
QCM
57
Quantinno Capital Management
New York
$218K +$91.9K +14,074 +76%
Wells Fargo
58
Wells Fargo
California
$210K +$30.3K +4,647 +17%
BHCM
59
Brevan Howard Capital Management
Jersey
$207K -$137K -20,959 -40%
Squarepoint
60
Squarepoint
New York
$195K -$130K -19,984 -41%
Invesco
61
Invesco
Georgia
$186K +$82.8K +12,680 +84%
MIM
62
MetLife Investment Management
New Jersey
$185K
T. Rowe Price Associates
63
T. Rowe Price Associates
Maryland
$172K +$22.9K +3,510 +16%
Verition Fund Management
64
Verition Fund Management
Connecticut
$151K
Mirae Asset Global ETFs Holdings
65
Mirae Asset Global ETFs Holdings
Hong Kong
$150K -$24.2K -3,708 -14%
A
66
AlphaQuest
New York
$136K
CPIG
67
Chicago Partners Investment Group
Illinois
$135K -$4.79K -734 -4%
PWM
68
Palumbo Wealth Management
New York
$134K +$131K +20,022 New
IIM
69
INTECH Investment Management
Florida
$133K -$35.1K -5,379 -21%
IC
70
IEQ Capital
California
$121K +$2.59K +397 +2%
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$115K -$9.36K -1,434 -8%
RC
72
Roundview Capital
New Jersey
$111K +$108K +16,500 New
CAPTRUST Financial Advisors
73
CAPTRUST Financial Advisors
North Carolina
$98.2K +$26.6K +4,070 +39%
Cerity Partners
74
Cerity Partners
New York
$95.1K +$20K +3,060 +28%
SPS
75
Susquehanna Portfolio Strategies
Pennsylvania
$93.4K +$90.9K +13,925 New

TMCI Hedge Fund Activity: Q3 2025 in Review

119 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2025, worth a combined $260M — up 15% from $226M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TMCI and 15 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 43 added.

The largest buyer was Opaleye Management, opening a new position worth an estimated $4.59M. The largest seller was Kornitzer Capital Management, exiting entirely with an estimated $2.15M sold.

  • 119 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2025, down from 125 in Q2 2025.
  • Funds reported $260M of Treace Medical Concepts stock for Q3 2025, up 15% quarter-over-quarter.
  • 15 funds opened new Treace Medical Concepts positions in Q3 2025 and 21 closed out, a net change of -6 holders.
  • The largest Treace Medical Concepts buyer in Q3 2025 was Opaleye Management, an estimated $4.59M added.
  • The largest Treace Medical Concepts seller in Q3 2025 was Kornitzer Capital Management, an estimated $2.15M sold.

Based on aggregated 13F filings for Q3 2025.